Cargando…

Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration

BACKGROUND: We present the results of a Phase 2a randomized controlled trial investigating the safety, and secondary endpoints of subretinal rAAV.sFLT-1 gene therapy in patients with active wet age-related macular degeneration (wAMD). METHODS: All patients (n = 32), (ClinicalTrials.gov; NCT01494805)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Constable, Ian J., Pierce, Cora M., Lai, Chooi-May, Magno, Aaron L., Degli-Esposti, Mariapia A., French, Martyn A., McAllister, Ian L., Butler, Steve, Barone, Samuel B., Schwartz, Steven D., Blumenkranz, Mark S., Rakoczy, Elizabeth P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161436/ https://www.ncbi.nlm.nih.gov/pubmed/27865764 http://dx.doi.org/10.1016/j.ebiom.2016.11.016

Ejemplares similares

Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
por: Han, Ruofan Connie, et al.
Publicado: (2021)

Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
por: Chandler, Laurel C., et al.
Publicado: (2021)

Subretinal recombinant tissue plasminogen activator and pneumatic displacement for the management of subretinal hemorrhage occurring after anti-VEGF injections for wet AMD
por: Tognetto, Daniele, et al.
Publicado: (2011)

Subretinal Neovascular Membrane in Wet Age-Related Macular Degeneration Managed With Intravitreal Ranibizumab
por: Sharma, Tanishq S, et al.
Publicado: (2021)

Evaluation of Lateral Spread of Transgene Expression following Subretinal AAV–Mediated Gene Delivery in Dogs
por: Bruewer, Ashlee R., et al.
Publicado: (2013)

Rod Outer Segment Development Influences AAV-Mediated Photoreceptor Transduction After Subretinal Injection
por: Petit, Lolita, et al.
Publicado: (2017)

Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates
por: Yiu, Glenn, et al.
Publicado: (2020)

Intravitreal air tamponade after AAV2 subretinal injection modifies retinal EGFP distribution
por: Ducloyer, Jean-Baptiste, et al.
Publicado: (2023)

Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye
por: Li, Wensheng, et al.
Publicado: (2009)

“Natural Regulators”: NK Cells as Modulators of T Cell Immunity
por: Schuster, Iona S., et al.
Publicado: (2016)

AAV2-Mediated Subretinal Gene Transfer of hIFN-α Attenuates Experimental Autoimmune Uveoretinitis in Mice
por: Tian, Lichun, et al.
Publicado: (2011)

Tropisms of AAV for Subretinal Delivery to the Neonatal Mouse Retina and Its Application for In Vivo Rescue of Developmental Photoreceptor Disorders
por: Watanabe, Satoshi, et al.
Publicado: (2013)

Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
por: Mowat, FM, et al.
Publicado: (2013)

Ly49C-Dependent Control of MCMV Infection by NK Cells Is Cis-Regulated by MHC Class I Molecules
por: Forbes, Catherine A., et al.
Publicado: (2014)

AAV2-Mediated Combined Subretinal Delivery of IFN-α and IL-4 Reduces the Severity of Experimental Autoimmune Uveoretinitis
por: Tian, Lichun, et al.
Publicado: (2012)

Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease
por: Jeyakumar, Jey M., et al.
Publicado: (2023)

A novel checkpoint in the Bcl-2–regulated apoptotic pathway revealed by murine cytomegalovirus infection of dendritic cells
por: Andoniou, Christopher E., et al.
Publicado: (2004)

AAV2-Mediated Subretinal Gene Transfer of mIL-27p28 Attenuates Experimental Autoimmune Uveoretinitis in Mice
por: Shao, Ju, et al.
Publicado: (2012)

Safety of Same-Eye Subretinal Sequential Readministration of AAV2-hRPE65v2 in Non-human Primates
por: Weed, Lindsey, et al.
Publicado: (2019)

Subretinal abscess
por: Pittenger, Brook, et al.
Publicado: (2017)

Inhibition of pathological brain angiogenesis through systemic delivery of AAV vector expressing soluble FLT1
por: Shen, Fanxia, et al.
Publicado: (2015)

Boosting Live Malaria Vaccine with Cytomegalovirus Vector Can Prolong Immunity through Innate and Adaptive Mechanisms
por: Gbedande, Komi, et al.
Publicado: (2023)

Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD
por: Reid, Christopher A., et al.
Publicado: (2018)

Efficacy and safety of eptinezumab in patients with migraine and self-reported aura: Post hoc analysis of PROMISE-1 and PROMISE-2
por: Ashina, Messoud, et al.
Publicado: (2022)

Chorioretinal Anastomosis for Central Retinal Vein Occlusion: A Review of Its Development, Technique, Complications, and Role in Management
por: McAllister, Ian L.
Publicado: (2020)

Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients
por: Degli Esposti, Luca, et al.
Publicado: (2014)

Drug adherence to olmesartan/amlodipine fixed combination in an Italian clinical practice setting
por: Degli Esposti, Luca, et al.
Publicado: (2014)

Treatment of old submacular hemorrhage by subretinal endoscopic surgery and intraoperative subretinal endoscopic findings
por: Yokoyama, Sho, et al.
Publicado: (2022)

M144, a Murine Cytomegalovirus (Mcmv)-Encoded Major Histocompatibility Complex Class I Homologue, Confers Tumor Resistance to Natural Killer Cell–Mediated Rejection
por: Cretney, Erika, et al.
Publicado: (1999)

Subretinal drusenoid deposits: An update
por: Monge, Manuel, et al.
Publicado: (2022)

The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides
por: Chirila, Traian V, et al.
Publicado: (2002)

Bcl-2 antagonists and cancer: from the clinic, back to the bench
por: Esposti, M Degli
Publicado: (2010)

Genome Analysis of Structure–Function Relationships in Respiratory Complex I, an Ancient Bioenergetic Enzyme
por: Degli Esposti, Mauro
Publicado: (2015)

Bioenergetic Evolution in Proteobacteria and Mitochondria
por: Degli Esposti, Mauro
Publicado: (2014)

A Journey across Genomes Uncovers the Origin of Ubiquinone in Cyanobacteria
por: Degli Esposti, Mauro
Publicado: (2017)

Late Mitochondrial Acquisition, Really?
por: Degli Esposti, Mauro
Publicado: (2016)

Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases
por: Esposti, Luca Degli, et al.
Publicado: (2013)

Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a ‘real-world’ retrospective cohort study
por: Degli Esposti, Luca, et al.
Publicado: (2016)

Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4
por: Borghi, Claudio, et al.
Publicado: (2013)

Wet and dry extremes reduce arthropod biomass independently of leaf phenology in the wet tropics
por: Newell, Felicity L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gjasdu1or1do1mf9uupvnjg6hf